Myriad Live - Let's talk rare hereditary genes with limited guidelines

Inside the GENOME

English - July 19, 2021 22:00 - 58 minutes - 40.5 MB
Medicine Health & Fitness Science genetics oncology cancer hereditary testing genetic testing brca cancer genetics Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: A look at breast cancer gene expression assays with Dr. Adam Brufsky

Next Episode: Myriad Live - Let's talk the pros and cons of germline testing for all breast cancer patients

Myriad Oncology Live episodes are recordings of an open-forum webinar hosted by Dr. Thomas Slavin. The opinions and views expressed in this recording do not necessarily represent those of Myriad Genetics or its affiliates. To participate in a future recording, visit myriad-oncology.com/myriad-oncology-live for a list of dates, times, and subjects.

Additional resources cited in this episode:
Hu et al NEJM - A population based study of genes previously implicated in Breast Cancer 2021. https://www.nejm.org/doi/pdf/10.1056/NEJMoa2005936

Palmer et al. JNCI paper - Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women. https://pubmed.ncbi.nlm.nih.gov/32427313/

Antoniou et al NEJM - Breast caner risk in families with mutations in PALB2 2014. https://pubmed.ncbi.nlm.nih.gov/25099575/

Yang et al 2020 PALB2 paper Dr. Couch referenced
https://pubmed.ncbi.nlm.nih.gov/31841383/

BCAC study - NEJM 2021 https://www.nejm.org/doi/full/10.1056/nejmoa1913948

Narod editorial to these two papers - CARRIERS and BCAC. https://www.nejm.org/doi/full/10.1056/NEJMe2035083?query=recirc_curatedRelated_article

BCAC Study paper titled: Breast Cancer Risk Genes - Association in More than 113,000 Women CARRIERS study is titled - A Population Based Study of Genes Previously Implicated in Breast Cancer